Clinical cases of biventricular arrhythmogenic cardiomyopathy with a variant in the DES gene

Svetlana M. Komissarova , Nadiia M. Rineiska , Natallia N. Chakova , Svetlana S. Niyazova , Iryna K. Haidzel

Cardiac Research ›› 2025, Vol. 1 ›› Issue (1) : 59 -66.

PDF (5051KB)
Cardiac Research ›› 2025, Vol. 1 ›› Issue (1) :59 -66. DOI: 10.1097/re9.0000000000000006
Case Report

Clinical cases of biventricular arrhythmogenic cardiomyopathy with a variant in the DES gene

Author information +
History +
PDF (5051KB)

Abstract

Mutations in the DES gene, which encodes the desmin protein, are associated with various forms of skeletal and/ or cardiac myopathies. Arrhythmogenic cardiomyopathy (ACM) due to a DES gene mutation is a rare form of desminopathy. In this article, we describe a familial case of biventricular ACM with early subclinical signs of myogenic involvement in the upper and lower limbs, initially manifesting with ventricular arrhythmias and progressive systolic dysfunction. Genetic analysis revealed a likely pathogenic variant c.358G>C (p.Ala120Pro, rs794728996) in exon 1 of the DES gene, located in the N-terminal region of the 1A helix domain. This variant affects filament assembly, leading to cytoplasmic aggregation of desmin, further supporting the functional importance of this region. Early implantation of an implantable cardioverter-defibrillator may contribute to primary prevention of sudden cardiac death in patients carrying this desmin variant. This is the first report of the phenotypic manifestations of the p.Ala120Pro variant in the DES gene in 2 patients with biventricular ACM from the same family.

Keywords

arrhythmogenic cardiomyopathy / desmin / systolic dysfunction / ventricular arrhythmia

Cite this article

Download citation ▾
Svetlana M. Komissarova, Nadiia M. Rineiska, Natallia N. Chakova, Svetlana S. Niyazova, Iryna K. Haidzel. Clinical cases of biventricular arrhythmogenic cardiomyopathy with a variant in the DES gene. Cardiac Research, 2025, 1(1): 59-66 DOI:10.1097/re9.0000000000000006

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Charron P , Arad M , Arbustini E , et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2010; 31: 2715- 26.

[2]

Henning RH , Brundel BJJM . Proteostasis in cardiac health and disease. Nat Rev Cardiol. 2017; 14: 637- 53.

[3]

Capetanaki Y , Papathanasiou S , Diokmetzidou A , Vatsellas G , Tsikitis M . Desmin related disease: a matter of cell survival failure. Curr Opin Cell Biol. 2015; 32: 113- 20.

[4]

van Tintelen JP , Van Gelder IC , Asimaki A , et al. Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene. Heart Rhythm. 2009; 6: 1574- 83.

[5]

Brodehl A , Dieding M , Klauke B , et al. The novel desmin mutant p.A120D impairs filament formation, prevents intercalated disk localization, and causes sudden cardiac death. Circ Cardiovasc Genet. 2013; 6: 615- 23.

[6]

van Spaendonck-Zwarts KY , van Hessem L , Jongbloed JD , et al. Desmin-related myopathy. Clin Genet. 2011; 80: 354- 66.

[7]

Clemen CS , Herrmann H , Strelkov SV , Schröder R . Desminopathies: pathology and mechanisms. Acta Neuropathol. 2013; 125: 47- 75.

[8]

Brodehl A , Dieding M , Biere N , et al. Functional characterization of the novel DES mutation p.L136P associated with dilated cardiomyopathy reveals a dominant filament assembly defect. J Mol Cell Cardiol. 2016; 91: 207- 14.

[9]

Protonotarios A , Brodehl A , Asimaki A , et al. The novel desmin variant p.Leu115Ile is associated with a unique form of biventricular arrhythmogenic cardiomyopathy. Can J Cardiol. 2021; 37: 857- 66.

[10]

Brodehl A , Holler S , Gummert J , Milting H . The N-Terminal part of the 1A domain of desmin is a hot spot region for putative pathogenic DES mutations affecting filament assembly. Cells. 2022; 11: 3906.

[11]

Richards S , Aziz N , Bale S , et al.; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17: 405- 24.

[12]

Elliott PM , Anastasakis A , Asimaki A , et al. Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report. Eur J Heart Fail. 2019; 21: 955- 64.

[13]

Protonotarios A , Elliott PM . Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management. Heart. 2019; 105: 1117- 28.

[14]

Azzimato V , Gennebäck N , Tabish AM , Buyandelger B , Knöll R . Desmin, desminopathy and the complexity of genetics. J Mol Cell Cardiol. 2016; 92: 93- 5.

[15]

Bermúdez-Jiménez FJ , Carriel V , Brodehl A , et al. Novel desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy/dysplasia. Circulation. 2018; 137: 1595- 610.

[16]

Bermudez-Jimenez FJ , Protonotarios A , García-Hernández S , et al. Phenotype and clinical outcomes in desmin-related arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol. 2024; 10: 1178- 90.

RIGHTS & PERMISSIONS

by the Authors, published by Wolters Kluwer Health, Inc. on behalf of Higher Education Press.

PDF (5051KB)

761

Accesses

0

Citation

Detail

Sections
Recommended

/